Cargando…

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state

The global COVID-19 pandemic is currently underway. In December 2020, the European Agency of Medicine (EMA) licensed the first Sars-CoV-2 vaccine. Therapeutic management of the COVID-19 positive patient should primarily aim to avoid the severe complications and organ injury caused by generalized inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848559/
https://www.ncbi.nlm.nih.gov/pubmed/33550151
http://dx.doi.org/10.1016/j.rmed.2021.106322